- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.56 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x ZN: ZINC ION(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
SAH.5: 18 residues within 4Å:- Chain A: M.138, G.139, W.140, S.174, Y.175, R.199, F.200, I.201, N.202, H.203, Y.244, F.248, W.249, F.256, T.257, C.258, Q.259, C.260
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:W.140, A:W.140, A:W.140, A:N.202, A:H.203, A:H.203, A:Q.259, A:C.260
- Water bridges: A:Y.175
SAH.27: 18 residues within 4Å:- Chain B: M.138, G.139, W.140, S.174, Y.175, R.199, F.200, I.201, N.202, H.203, Y.244, F.248, W.249, F.256, T.257, C.258, Q.259, C.260
11 PLIP interactions:11 interactions with chain B- Hydrogen bonds: B:W.140, B:W.140, B:W.140, B:S.174, B:Y.175, B:N.202, B:H.203, B:H.203, B:Q.259, B:C.260
- pi-Stacking: B:W.249
- 2 x CIQ: 2-cyclohexyl-6-methoxy-N-[1-(1-methylethyl)piperidin-4-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine(Non-covalent)
CIQ.6: 14 residues within 4Å:- Chain A: Y.157, D.164, A.167, D.168, R.170, D.173, S.174, L.176, F.177, D.178, F.242, Y.244, F.248, I.251
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:Y.157, A:D.164, A:A.167, A:L.176, A:L.176
- Hydrogen bonds: A:D.173, A:D.173
- pi-Cation interactions: A:Y.244
CIQ.28: 16 residues within 4Å:- Chain B: Y.157, D.164, A.167, D.168, R.170, D.173, S.174, Y.175, L.176, F.177, D.178, F.242, Y.244, F.248, I.251
- Ligands: UNX.40
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:Y.157, B:D.164, B:A.167, B:L.176, B:L.176
- Hydrogen bonds: B:D.173
- Salt bridges: B:D.168
- 29 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.7: 2 residues within 4Å:- Chain A: C.13, R.14
Ligand excluded by PLIPUNX.8: 5 residues within 4Å:- Chain A: I.126, K.127, V.128, F.153, I.154
Ligand excluded by PLIPUNX.9: 4 residues within 4Å:- Chain A: N.46, E.48, R.56
- Ligands: UNX.22
Ligand excluded by PLIPUNX.10: 1 residues within 4Å:- Chain A: E.21
Ligand excluded by PLIPUNX.11: 6 residues within 4Å:- Chain A: N.97, K.98, E.100, P.101, P.102
- Ligands: UNX.19
Ligand excluded by PLIPUNX.12: 6 residues within 4Å:- Chain A: C.77, S.81, C.84, I.104, F.105, N.119
Ligand excluded by PLIPUNX.13: 6 residues within 4Å:- Chain A: V.23, P.24, I.25, P.26, R.129, L.130
Ligand excluded by PLIPUNX.14: 3 residues within 4Å:- Chain A: G.19, Y.20, E.21
Ligand excluded by PLIPUNX.15: 3 residues within 4Å:- Chain A: Q.123, R.225
- Ligands: UNX.16
Ligand excluded by PLIPUNX.16: 3 residues within 4Å:- Chain A: Q.123, R.225
- Ligands: UNX.15
Ligand excluded by PLIPUNX.17: 2 residues within 4Å:- Chain A: N.53, R.222
Ligand excluded by PLIPUNX.18: 4 residues within 4Å:- Chain A: F.96, N.97, K.98, I.99
Ligand excluded by PLIPUNX.19: 5 residues within 4Å:- Chain A: W.85, F.96, N.97, P.102
- Ligands: UNX.11
Ligand excluded by PLIPUNX.20: 6 residues within 4Å:- Chain A: V.214, F.215, M.216, H.218, F.223, R.225
Ligand excluded by PLIPUNX.21: 1 residues within 4Å:- Chain A: E.45
Ligand excluded by PLIPUNX.22: 4 residues within 4Å:- Chain A: C.47, E.48
- Chain B: R.56
- Ligands: UNX.9
Ligand excluded by PLIPUNX.29: 5 residues within 4Å:- Chain B: P.101, P.102, L.103, V.212, R.213
Ligand excluded by PLIPUNX.30: 5 residues within 4Å:- Chain B: F.215, M.216, L.217, H.218
- Ligands: UNX.36
Ligand excluded by PLIPUNX.31: 2 residues within 4Å:- Chain A: E.45
- Chain B: E.45
Ligand excluded by PLIPUNX.32: 1 residues within 4Å:- Chain B: Y.193
Ligand excluded by PLIPUNX.33: 2 residues within 4Å:- Chain B: N.22, G.125
Ligand excluded by PLIPUNX.34: 2 residues within 4Å:- Chain B: Q.123, R.225
Ligand excluded by PLIPUNX.35: 3 residues within 4Å:- Chain B: D.68, D.69, C.117
Ligand excluded by PLIPUNX.36: 7 residues within 4Å:- Chain B: V.214, F.215, H.218, F.223, P.224, R.225
- Ligands: UNX.30
Ligand excluded by PLIPUNX.37: 5 residues within 4Å:- Chain B: C.66, D.68, C.70, S.71, S.72
Ligand excluded by PLIPUNX.38: 7 residues within 4Å:- Chain B: D.15, A.17, G.19, Y.20, E.21, V.23, P.24
Ligand excluded by PLIPUNX.39: 3 residues within 4Å:- Chain B: T.135, A.136, G.139
Ligand excluded by PLIPUNX.40: 3 residues within 4Å:- Chain B: D.178, R.247
- Ligands: CIQ.28
Ligand excluded by PLIPUNX.41: 4 residues within 4Å:- Chain B: N.46, L.161, H.218, R.225
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vedadi, M. et al., A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat.Chem.Biol. (2011)
- Release Date
- 2011-05-04
- Peptides
- Histone-lysine N-methyltransferase EHMT2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.56 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x ZN: ZINC ION(Non-covalent)
- 2 x SAH: S-ADENOSYL-L-HOMOCYSTEINE(Non-covalent)
- 2 x CIQ: 2-cyclohexyl-6-methoxy-N-[1-(1-methylethyl)piperidin-4-yl]-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine(Non-covalent)
- 29 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vedadi, M. et al., A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat.Chem.Biol. (2011)
- Release Date
- 2011-05-04
- Peptides
- Histone-lysine N-methyltransferase EHMT2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B